Biogen’s Chief Medical Officer calls the results “a shot in the arm.” An analyst calls the noise “deafening.” A doctor sees potential help for patients.
Highly Anticipated Data On Would-Be Alzheimer’s Drug Raises Hope And Questions
Biogen’s Chief Medical Officer calls the results “a shot in the arm.” An analyst calls the noise “deafening.” A doctor sees potential help for patients.